Cupid Limited Q4 Results 2026 Preview: Date, Time, Expectations & Key Things To Watch
Cupid Limited enters its Q4 FY26 earnings release following a period of rapid expansion across its sexual wellness, FMCG, and diagnostics divisions. Investors are closely watching the company's ability to sustain its record-breaking margin trajectory while simultaneously scaling its Palava manufacturing facility and executing on strategic retail investments.
| Results date | 2026-05-15 |
|---|---|
| Quarter | Q4 FY26 |
| Previous quarter revenue | Rs. 93.50 Cr |
| Previous quarter PAT | Rs. 32.83 Cr |
| Previous quarter EBITDA margin | 37% |
| Market cap | Rs. 16687.26 Cr |
| CMP | Rs. 124.1 |
Cupid Limited Q4 Results Date and Time
The company has scheduled a board meeting for May 15, 2026, to consider and approve the audited financial results for Q4 and FY26.
What to expect from Cupid Limited's Q4 FY26 results
In its most recently reported quarter, Cupid Limited posted revenue of Rs. 93.50 Cr, PAT of Rs. 32.83 Cr, and an EBITDA margin of 37%. The company is maintaining strong momentum in its B2C segment, which reached a revenue contribution of 14% in FY25, as it works toward its FY26 B2C revenue target of Rs. 125 Cr.
Management has highlighted that the order book is at its highest level to date, with the South Africa 5-year program contributing an annual allocation of approximately Rs. 115 Cr through 2030. Furthermore, the diagnostics business continues to scale, with a current capacity of 1.5 lakh kits per day and a target to reach 4 lakh kits per day by the end of 2026.
Key Things To Watch
Performance vs Guidance Tracking: Tracking progress against FY26 financial and operational targets.
- Revenue — Exceed Rs. 335 Cr — 9M revenue of Rs. 259.36 Cr tracking ahead
- Net Profit — Exceed Rs. 100 Cr — 9M net profit of Rs. 71.97 Cr tracking ahead
- Retail Touchpoints — 1.80 lakh — 1.50 lakh+ achieved
Strategic Updates: Key project milestones and expansion progress.
- Palava manufacturing facility construction progress toward end-CY2026 commissioning
- Saudi Arabia FMCG facility approval status and land identification
- Baazar Style Retail store rollout progress, currently at 260+ stores with a 500+ store target
Operational Focus Areas: Key business drivers and market expansion.
- South Africa 5-year program execution ongoing since December 2025
- IVD kit CE certification progress for European market entry
- NBR Female Condom R&D progress and market entry timeline
Risks and headwinds to monitor: Management-flagged operational and regulatory risks.
- Administrative warning letter dated April 23, 2026, regarding Regulation 30(7) of SEBI LODR
- Raw material price volatility in latex and silicon oil markets
- Trade receivable cycle of approximately 120 days impacting working capital
Ask about this
Ask Cofacto a question about this company. Answers cite filings and company data.
Frequently Asked Questions
When will Cupid Limited announce Q4 FY 2025-2026 results?
Cupid Limited will announce its Q4 FY 2025-2026 results on May 15, 2026.
What was Cupid Limited's revenue in its previous quarter?
In Q3 FY26, Cupid Limited reported revenue from operations of Rs. 93.50 Cr.
What is Cupid Limited's current market capitalisation?
Cupid Limited's current market capitalisation is Rs. 16,687.26 Cr.
What is the timeline for the Palava manufacturing facility commissioning?
The Palava manufacturing facility is targeted for commissioning by the end of CY2026. This facility is expected to add 770 million male condoms and 75 million female condoms to annual capacity.
Is Cupid Limited on track with its previously stated revenue guidance?
Yes, the company is tracking ahead of its FY26 revenue guidance of Rs. 335 Cr. The company reported Rs. 259.36 Cr in revenue for the first nine months of the financial year.